“The Center for Psychedelic Therapies” has the vision of an alternative approach for the treatment of mental conditions through the use of psychedelic medicines. At present, we offer Ketamine as a sole therapeutic agent and plan to incorporate MDMA and Psilocybin once these have been approved and accepted as safe and effective treatment by regulatory entities within the USA. It is paramount to emphasize that the Center for Psychedelic Therapies approach is primarily a psychotherapy-based practice; assisted by IV Ketamine.